Bozena Jaentschke Centre for Vaccine Evaluation, Biologics and Genetic Therapies Directorate, HPFB Health canada Biography Publications Institution JoVE Articles Bozena Jaentschke has not added a biography. If you are Bozena Jaentschke and would like to personalize this page please email our Author Liaison for assistance. Publications Qualitative and Quantitative Analyses of Virtually All Subtypes of Influenza A and B Viral Neuraminidases Using Antibodies Targeting the Universally Conserved Sequences Vaccine. Aug, 2010 | Pubmed ID: 20621113 A Simple Slot Blot for the Detection of Virtually All Subtypes of the Influenza A Viral Hemagglutinins Using Universal Antibodies Targeting the Fusion Peptide Nature Protocols. 2010 | Pubmed ID: 20010723 SARS Coronavirus: Unusual Lability of the Nucleocapsid Protein Biochemical and Biophysical Research Communications. Dec, 2008 | Pubmed ID: 18926799 Cytotoxic Doses of Ketoconazole Affect Expression of a Subset of Hepatic Genes Journal of Toxicology and Environmental Health. Part A. Nov, 2007 | Pubmed ID: 17966066 Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays Caroline Gravel*1, Changgui Li*2, Junzhi Wang2, Anwar M Hashem1,3,4, Bozena Jaentschke1, Gary Van Domselaar5, Runtao He5, Xuguang Li1,3 1Centre for Vaccine Evaluation, Biologics and Genetic Therapies Directorate, HPFB, Health canada, 2National Institute for the Control of Pharmaceutical and Biological Products, The State Food and Drug Administration, Beijing, 3Department of Biochemistry, Microbiology and Immunology, University of Ottawa, 4Microbiology Department, Faculty of Medicine, King Abdulaziz University, 5National Microbiology Laboratory, Public Health Agency of Canada JoVE 2784 Immunology and Infection
Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays Caroline Gravel*1, Changgui Li*2, Junzhi Wang2, Anwar M Hashem1,3,4, Bozena Jaentschke1, Gary Van Domselaar5, Runtao He5, Xuguang Li1,3 1Centre for Vaccine Evaluation, Biologics and Genetic Therapies Directorate, HPFB, Health canada, 2National Institute for the Control of Pharmaceutical and Biological Products, The State Food and Drug Administration, Beijing, 3Department of Biochemistry, Microbiology and Immunology, University of Ottawa, 4Microbiology Department, Faculty of Medicine, King Abdulaziz University, 5National Microbiology Laboratory, Public Health Agency of Canada JoVE 2784 Immunology and Infection